EyePoint Pharmaceuticals (EYPT) News Today

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

$17.65

+0.15 (+0.86%)

(As of 04/19/2024 ET)

Source

Source	Headline
	Buy Recommendation: EyePoint Pharmaceuticals’ Promising Outlook with EYP-1901 for Diabetic Retinopathy and AMD markets.businessinsider.com - April 19 at 2:14 PM
	EyePoint Pharmaceuticals (NASDAQ:EYPT) Sees Strong Trading Volume marketbeat.com - April 18 at 1:56 PM
	EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Up 2% marketbeat.com - April 16 at 1:40 PM
	EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) globenewswire.com - April 16 at 7:00 AM
	EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Down 5.7% marketbeat.com - April 15 at 2:50 PM
	35,000 Shares in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Purchased by DekaBank Deutsche Girozentrale marketbeat.com - April 15 at 5:16 AM
	Strong Buy Rating for EyePoint Pharmaceuticals Amid Promising Developments in Ophthalmic Therapies markets.businessinsider.com - April 13 at 8:53 AM
	EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $21.53 americanbankingnews.com - April 12 at 5:22 AM
	EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Recommendation of "Buy" from Brokerages americanbankingnews.com - April 12 at 2:20 AM
	EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Recommendation of "Buy" from Analysts marketbeat.com - April 12 at 2:17 AM
	EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists globenewswire.com - April 2 at 7:00 AM
	EyePoint Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:EYPT) marketbeat.com - March 21 at 11:26 AM
	EyePoint Pharmaceuticals (NASDAQ:EYPT) Trading 4.7% Higher marketbeat.com - March 19 at 3:33 PM
	EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) globenewswire.com - March 18 at 7:00 AM
	EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Average Recommendation of "Buy" by Brokerages marketbeat.com - March 18 at 2:23 AM
	EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Down 4.2% marketbeat.com - March 13 at 2:16 PM
	EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $24.40 marketbeat.com - March 11 at 11:01 AM
	Scotia Capital Inc. Has $727,000 Stock Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) marketbeat.com - March 10 at 7:23 AM
	EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Analysts Just Slashed This Year's Revenue Estimates By 22% finance.yahoo.com - March 9 at 9:59 AM
	EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares Sold by Adage Capital Partners GP L.L.C. marketbeat.com - March 9 at 6:35 AM
	Buy Rating Affirmed for EyePoint Pharmaceuticals Amidst Promising Clinical Trials and Market Expansion Potential markets.businessinsider.com - March 8 at 6:58 PM
	Critical Insights From EyePoint Pharmaceuticals Analyst Ratings: What You Need To Know markets.businessinsider.com - March 8 at 6:58 PM
	EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2023 Earnings Call Transcript finance.yahoo.com - March 8 at 1:58 PM
	EyePoint Pharmaceuticals (NASDAQ:EYPT) Issues Quarterly Earnings Results marketbeat.com - March 8 at 11:23 AM
	EyePoint Pharmaceuticals Full Year 2023 Earnings: Beats Expectations finance.yahoo.com - March 8 at 8:58 AM
	Q4 2023 EyePoint Pharmaceuticals Inc Earnings Call finance.yahoo.com - March 8 at 1:13 AM
	EyePoint Pharmaceuticals Inc (EYPT) Reports Growth Amidst Strategic Shifts in Q4 and Full-Year 2023 finance.yahoo.com - March 7 at 3:13 PM
	EYPT Stock Earnings: EyePoint Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023 investorplace.com - March 7 at 2:01 PM
	EyePoint Pharmaceuticals, Inc. (EYPT) Q4 2023 Earnings Conference Call Transcript seekingalpha.com - March 7 at 12:29 PM
	EyePoint Pharmaceuticals GAAP EPS of -$0.33 beats by $0.16, revenue of $14M beats by $5.3M msn.com - March 7 at 10:13 AM
	EyePoint Pharmaceuticals: Strategic Leadership Appointment and Positive Developments Bolster Buy Rating markets.businessinsider.com - March 7 at 10:13 AM
	EyePoint Pharmaceuticals: Q4 Earnings Snapshot washingtonpost.com - March 7 at 10:13 AM
	EyePoint Pharmaceuticals, Inc. to Post FY2024 Earnings of ($1.83) Per Share, Capital One Financial Forecasts (NASDAQ:EYPT) marketbeat.com - March 7 at 7:37 AM
	EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments globenewswire.com - March 7 at 7:00 AM
	104,618 Shares in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Bought by Trexquant Investment LP marketbeat.com - March 7 at 5:40 AM
	EyePoint Pharmaceuticals Q4 2023 Earnings Preview msn.com - March 6 at 6:52 PM
	A Preview Of EyePoint Pharmaceuticals's Earnings benzinga.com - March 6 at 6:52 PM
	Sectoral Asset Management Inc. Sells 135,197 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) marketbeat.com - March 6 at 10:15 AM
	EyePoint Pharmaceuticals, Inc. to Post FY2028 Earnings of $8.32 Per Share, Capital One Financial Forecasts (NASDAQ:EYPT) marketbeat.com - March 6 at 8:33 AM
	Buy Rating Affirmed for EyePoint Pharmaceuticals Amid Strategic Leadership Changes and Promising Pipeline Outlook markets.businessinsider.com - March 5 at 1:15 AM
	EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer finanznachrichten.de - March 4 at 10:14 AM
	EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer globenewswire.com - March 4 at 7:00 AM
	Acuta Capital Partners LLC Sells 81,872 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) marketbeat.com - March 3 at 12:18 PM
	EyePoint Pharmaceuticals (EYPT) to Release Quarterly Earnings on Thursday marketbeat.com - March 1 at 2:55 PM
	UBS Group AG Acquires 437,190 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) marketbeat.com - March 1 at 4:28 AM
	EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2024 finance.yahoo.com - February 29 at 7:16 AM
	EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2024 globenewswire.com - February 29 at 7:00 AM
	EyePoint Pharmaceuticals (NASDAQ:EYPT) Sees Unusually-High Trading Volume marketbeat.com - February 27 at 12:31 PM
	EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences globenewswire.com - February 27 at 7:00 AM
	Barclays PLC Acquires 23,208 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) marketbeat.com - February 27 at 4:16 AM

Get EyePoint Pharmaceuticals News Delivered to You Automatically

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

EYPT Media Mentions By Week

EYPT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EYPT
News Sentiment
▼
0.73

0.52
▲
Average
Medical
News Sentiment

EYPT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EYPT Articles
This Week
▼
7

4
▲
EYPT Articles
Average Week

Get EyePoint Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:EYPT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

EyePoint Pharmaceuticals (EYPT) News Today

EYPT Media Mentions By Week

EYPT Media Sentiment

EYPT News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info